Probiotics are live microorganisms found in leaves that are used as food additives to provide health benefits. Probiotic yeasts are typical non-pathogenic strains of Saccharomyces cerevisiae origin. Due to yeast’s natural resistance to antibacterial antibiotics, probiotic yeast is considered superior to probiotic bacteria.
The use of probiotic yeasts in animal feed has a positive effect on health by increasing fiber digestibility and increasing animal performance, which increases meat, milk and egg yield. Researchers from the Central Food Technological Research Institute (CFTRI) in Mysore and a US counterpart have shown that food-derived probiotic yeasts help minimize the toxicity of certain deadly fungi that have become resistant to common antifungal drugs.
Probiotic yeasts are especially effective against Candida Auris, which has been scared after drug-resistant variants. The increasing use of probiotic yeast in pharmaceuticals has widened the growth scope of the probiotic yeast market.
Rising demand for high-quality animal by-products has expanded the growth potential of the probiotic yeast market
The use of probiotic yeast in ruminant feed has improved health and increased milk production. Similarly, in pigs, probiotic yeast induces an immune response to reduce the entry of pathogens into the body and also reduces post-weaning diarrhea. Probiotic yeasts, in particular Saccharomyces cerevisiae, are often used in dairy cows. A recent study found that the use of probiotic yeast in cow feeding improved the reproductive performance of dairy cows. Dietary supplements are an established strategy for improving performance across a variety of parameters in livestock. With the increasing use of probiotics for animal feed, growth promotion and gut health development, the probiotic yeast market is expected to show the fastest growth during the forecast period.
Emergence of Saccharomyces boulardii as a potential probiotic organism to positively influence the demand for the probiotic yeast market
Saccharomyces boulardii is emerging as a potential probiotic organism. S. boulardii is a probiotic yeast used in the treatment of specific intestinal and digestive diseases. This probiotic yeast has shown promise in the prevention of enteral nutrition-related diarrhea, acute gastroenteritis and traveller’s diarrhea. It is a probiotic supplement used around the world to promote gastrointestinal health.
Global Probiotic Yeast Market: Key Players:
Some of the key players doing their business in the global probiotic yeast market are Mystical Biotech, BIOGIT, Angel Yeast Co. Ltd., Jarrow Formulas, Pharma Nord, Lesaffre and others.
- BIOGIT ® is the first non-pathogenic probiotic yeast developed nationally, patented worldwide. BIOGIT ®, produced from live yeast cells, restores the disturbed microbial gastrointestinal balance and is an optimal probiotic for all ages.
- Lesaffre Human developed the first known probiotic yeast that directly addresses the symptoms of irritable bowel syndrome (IBS). Lesaffre Human Care’s patented strain of Saccharomyces cerevisiae, with a clinically proven effect in relieving intestinal problems in individuals with IBS.